Follow
Dumitru Lupuliasa
Dumitru Lupuliasa
UMF Carol Davila București, România
Verified email at umfcd.ro
Title
Cited by
Cited by
Year
Flow and thixotropic parameters for rheological characterization of hydrogels
MV Ghica, M Hîrjău, D Lupuleasa, CE Dinu-Pîrvu
Molecules 21 (6), 786, 2016
1662016
Chitosan-based in situ gels for ocular delivery of therapeutics: a state-of-the-art review
T Irimia, CE Dinu-Pîrvu, MV Ghica, D Lupuleasa, DL Muntean, DI Udeanu, ...
Marine drugs 16 (10), 373, 2018
1362018
Development and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazole
G Coneac, V Vlaia, I Olariu, AM Muţ, DF Anghel, C Ilie, C Popoiu, ...
Aaps Pharmscitech 16, 889-904, 2015
952015
Cellulose-derivatives-based hydrogels as vehicles for dermal and transdermal drug delivery
L Vlaia, G Coneac, I Olariu, V Vlaia, D Lupuleasa
Emerging concepts in analysis and applications of hydrogels 2, 64, 2016
872016
Enhancement of solubility and dissolution rate of different forms of atorvastatin calcium in direct compression tablet formulas
SW Ahjel, D Lupuleasa
Farmacia 57 (3), 290-300, 2009
612009
Development, optimization and in vitro/in vivo characterization of collagen-dextran spongious wound dressings loaded with flufenamic acid
MV Ghica, MG Albu Kaya, CE Dinu-Pîrvu, D Lupuleasa, DI Udeanu
Molecules 22 (9), 1552, 2017
572017
New opportunity to formulate intranasal vaccines and drug delivery systems based on chitosan
R Popescu, MV Ghica, CE Dinu-Pîrvu, V Anuța, D Lupuliasa, L Popa
International Journal of Molecular Sciences 21 (14), 5016, 2020
502020
Pelletization techniques used in pharmaceutical fields
M Hirjau, AC Nicoara, V Hirjau, D Lupuleasa
Practica farmaceutica 4 (3), 206-211, 2011
462011
The Age of Pharmaceutical 3D Printing. Technological and Therapeutical Implications of Additive Manufacturing.
IB Dumitrescu, D Lupuliasa, C DRĂGOI, AC NICOLAE, A Pop, ...
Farmacia 66 (3), 2018
422018
INSIGHTS INTO CHRONONUTRITION: THE INNERMOST INTERPLAY AMONGST NUTRITION, METABOLISM AND THE CIRCADIAN CLOCK, IN THE CONTEXT OF EPIGENETIC REPROGRAMMING.
C DRĂGOI, E MOROŞAN, IB Dumitrescu, AC NICOLAE, AL ARSENE, ...
Farmacia 67 (4), 2019
372019
The polyphenolic profile and antioxidant activity of five vegetal extracts with hepatoprotective potential
L Costea, CL Chițescu, R Boscencu, M Ghica, D Lupuliasa, DP Mihai, ...
Plants 11 (13), 1680, 2022
312022
Investigation of cyclodextrin based nanosponges complexes with angiotensin I converting enzyme inhibitors (Enalapril, captopril, cilazapril)
AA Olteanu, CC Arama, C Bleotu, D Lupuleasa, CM Monciu
Farmacia 63 (492-503), 1, 2015
302015
Modern aspects regarding the microbial spoilage of pharmaceutical products
OH Kamil, D Lupuliasa
Farmacia 59 (2), 133-46, 2011
302011
A NEW ERA FOR THE THERAPEUTIC MANAGEMENT OF THE ONGOING COVID-19 PANDEMIC.
AL ARSENE, IB Dumitrescu, C DRĂGOI, DI Udeanu, D Lupuliasa, V Jinga, ...
Farmacia 68 (2), 2020
292020
Ultraviolet filters for cosmetic applications
G Nitulescu, D Lupuliasa, I Adam-Dima, GM Nitulescu
Cosmetics 10 (4), 101, 2023
282023
Phenolic Secondary Metabolites and Antiradical and Antibacterial Activities of Different Extracts of Usnea barbata (L.) Weber ex F.H.Wigg from Călimani Mountains …
V Popovici, L Bucur, CE Gîrd, A Popescu, E Matei, GC Cozaru, ...
Pharmaceuticals 15 (7), 829, 2022
282022
Escaping the economic turn down through performing employees, creative leaders and growth driver capabilities in the Romanian pharmaceutical industry
MP Raţiu, I Purcărea, F Popa, VL Purcărea, TV Purcărea, D Lupuleasa, ...
Farmacia 59 (1), 119-130, 2011
282011
Cardiovascular risk assessment in osteoporotic patients using osteoprotegerin as a reliable predictive biochemical marker
CG Barbu, AL Arsene, S Florea, A Albu, A Sirbu, S Martin, AC Nicolae, ...
Molecular Medicine Reports 16 (5), 6059-6067, 2017
262017
Tehnologie farmaceutică: tehnologie farmaceutică generală, forme farmaceutice ca sisteme disperse omogene, forme farmaceutice sterile:[tratat]
I Popovici, D Lupuleasa
Polirom, 2017
262017
Physico-chemical and pharmaco-technical characterization of inclusion complexes formed by rutoside with β-cyclodextrin and hydroxypropyl-β-cyclodextrin used to develop solid …
T Balaci, B Velescu, O Karampelas, AM Musuc, GM Nițulescu, EA Ozon, ...
Processes 9 (1), 26, 2020
242020
The system can't perform the operation now. Try again later.
Articles 1–20